Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/10/2003WO2003029437A2 Secreted proteins
04/10/2003WO2003029436A2 Ul16 binding protein 4
04/10/2003WO2003029434A2 Novel molecules of the hkid-1-related protein family and uses thereof
04/10/2003WO2003029433A2 Chimeric viral vectors for gene therapy
04/10/2003WO2003029431A2 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
04/10/2003WO2003029430A2 Tandem repeat markers
04/10/2003WO2003029429A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells
04/10/2003WO2003029426A2 Human and murine cytokine polypeptides
04/10/2003WO2003029425A2 Whole cell engineering using real-time metabolic flux analysis
04/10/2003WO2003029424A2 Novel proteins and nucleic acids encoding same
04/10/2003WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003WO2003029420A2 Apo-2 ligand variants and uses thereof
04/10/2003WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
04/10/2003WO2003029416A2 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof
04/10/2003WO2003029413A2 A novel g protein-coupled receptor, gave 10
04/10/2003WO2003029412A2 Restricted expression lentivial vectors
04/10/2003WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
04/10/2003WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule
04/10/2003WO2003029408A2 Esr2 - a plant gene that can promote plant regeneration and transformation
04/10/2003WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003WO2003029405A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
04/10/2003WO2003029404A2 MAST CELL RasGRP4 COMPOSITIONS AND RELATED METHODS
04/10/2003WO2003029400A2 Cell lines for productive infection of hepatitis b virus
04/10/2003WO2003029399A2 Regulatory sequence for the specific expression in fruit of a gene and the applications thereof
04/10/2003WO2003029295A1 Human tissue factor antibodies
04/10/2003WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy
04/10/2003WO2003029291A2 Pegylated and diglycosylated erythropoietin
04/10/2003WO2003029290A1 Drug transporter and use thereof
04/10/2003WO2003029289A2 Fragements of heat shock proteins and their use
04/10/2003WO2003029288A2 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
04/10/2003WO2003029286A1 Fluorescent proteins
04/10/2003WO2003029285A2 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
04/10/2003WO2003029282A2 Tumor-peptide antigens from the human prdi-bf1-protein
04/10/2003WO2003029278A2 Il10-r: modulators of lymphocyte activation
04/10/2003WO2003029277A2 Modulators of lymphocyte activation and migration
04/10/2003WO2003029274A2 Paramyxoviruses as gene transfer vectors to lung cells
04/10/2003WO2003029266A1 Antisense modulation of vascular endothelial growth factor receptor-2 expression
04/10/2003WO2003028764A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
04/10/2003WO2003028666A2 Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
04/10/2003WO2003028661A2 Adjuvanted meningococcus compositions
04/10/2003WO2003028656A2 Adjuvant compositions
04/10/2003WO2003028637A2 Antisense modulation of sphingosine-1-phosphate lyase expression
04/10/2003WO2003028636A2 Antisense modulation of il-1 receptor-associated kinase-4 expression
04/10/2003WO2003028632A2 Development of a preventive vaccine for filovirus infection in primates
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028621A2 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
04/10/2003WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003028478A2 Identity preserved crop production
04/10/2003WO2003028445A1 Tsa2306 knockout non-human animal
04/10/2003WO2003028444A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto
04/10/2003WO2003028443A1 Screening methods for agents that modulate degenerative disorders associated with bcl-2-and bim
04/10/2003WO2003028432A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
04/10/2003WO2003020979A8 Methods for preparing nucleic acid samples
04/10/2003WO2003017935A9 Human antibodies specific for interleukin 15 (il-15)
04/10/2003WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity
04/10/2003WO2003012033A3 Antisense modulation of short heterodimer partner-1 expression
04/10/2003WO2003010193A3 Genes and proteins for the biosynthesis of rosaramicin
04/10/2003WO2003008575A3 Dna sequences for regulating transcription
04/10/2003WO2003008572A8 Methods of creating genetic diversity
04/10/2003WO2003006607A9 Inhibition of apoptosis process and improvement of cell performance
04/10/2003WO2003005812A3 Modulation of metabolism of steroids and xenobiotics
04/10/2003WO2003002598A3 Peptides for use as translocation factors
04/10/2003WO2003000861A9 Eukaryotic genes involved in adult lifespan regulation
04/10/2003WO2003000114A3 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
04/10/2003WO2002102768A3 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
04/10/2003WO2002101051A3 Genes and proteins for the biosynthesis of anthramycin
04/10/2003WO2002101019A3 Methods of culturing animal cells and polypeptide production in animal cells
04/10/2003WO2002100882A3 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
04/10/2003WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
04/10/2003WO2002099091A3 Endo-beta-1,4-glucanase from bacillus
04/10/2003WO2002098911A3 Insecticidal proteins and synergistic combinations thereof
04/10/2003WO2002098365A3 Conditioned cell culture media and uses thereof
04/10/2003WO2002096467A3 Pharmaceutical use for secreted bacterial effector proteins
04/10/2003WO2002092799A3 Regulation of human steroid 5-alpha reductase-like protein
04/10/2003WO2002088360A3 Haemophilus influenzae antigens
04/10/2003WO2002081704A3 Regulation of human protein kinase-like protein
04/10/2003WO2002081668A8 Desaturase genes and uses thereof
04/10/2003WO2002080982A9 Nucleic acid mucosal immunization
04/10/2003WO2002079463A3 Methods for modification of plant inflorescence architecture
04/10/2003WO2002072826A3 Neurotrophic factors
04/10/2003WO2002072783A3 Identification of cellular targets for biologically active molecules
04/10/2003WO2002070692A3 Abca9 transporter and uses thereof
04/10/2003WO2002068602A8 Methods for modulating g2a receptor activity
04/10/2003WO2002063013A3 Human acid phosphatase gene
04/10/2003WO2002062201A3 Rare event detection system
04/10/2003WO2002061082A3 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep)
04/10/2003WO2002059589A3 Multi-channel bio-separation cartridge
04/10/2003WO2002059311A3 Colon cancer marker
04/10/2003WO2002059297A3 A library of a collection of cells
04/10/2003WO2002059290A3 A method for evolving a cell having desired phenotype and envolved cells
04/10/2003WO2002059282A3 Adipocyte complement related protein zacrp13
04/10/2003WO2002057476A9 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa)
04/10/2003WO2002057460A3 Polynucleotides encoding human phosphatases
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002055688A3 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
04/10/2003WO2002054862A3 TRANSGENIC MICE CONTAINING Kv8.1 POTASSIUM CHANNEL ALPHA SUBUNIT GENE DISRUPTIONS
04/10/2003WO2002053732A3 Methods for making polynucleotide libraries, polynucleotide arrays, and cell librraries for high-throughput genomics analysis
04/10/2003WO2002050285A9 Histone deacetylase-related gene and protein
1 ... 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 ... 4023